A catheter is a thin, flexible medical tube used for draining fluids, delivering medications, monitoring body functions, or guiding surgical tools inside the body. Catheters are used in cardiology, neurology, urology, intravenous therapy, emergency care, and several diagnostic procedures. Their improved designs, coatings, and materials have made modern catheters safer and more efficient, which further fuels market growth.
The global Catheter Market reached USD 57,912 Million in 2024 and is set to expand steadily in the coming years. According to MarketsGlob, the market is expected to touch USD 94,217.61 Million by 2031, growing at a 7.2% CAGR from 2025 to 2031. This growth is fueled by rising chronic illnesses, increasing surgical procedures, and a shift toward safer, faster, and minimally invasive treatment options.
Rising Adoption of Advanced Catheter Technologies
The demand for catheters continues to rise due to increasing cardiology and urology cases globally. Hospitals are shifting toward minimally invasive procedures, as they offer faster recovery, reduced complications, and minimal scarring. Moreover, chronic diseases like diabetes, kidney disorders, and cardiovascular ailments are increasing the usage of long-term and short-term catheters.
In addition, coating innovations—such as antimicrobial, hydrophilic, and anti-thrombogenic coatings—are improving patient comfort and reducing infection risks. As healthcare infrastructure in emerging nations continues to grow, catheter usage is rising significantly in India, China, Southeast Asia, and parts of Latin America.
Industry News: Product Launches, Contracts & Regulatory Updates
The catheter industry saw several important updates in 2024 and 2025, especially from top global players:
Teleflex Remains the Most Active Company in 2024–2025
-
January 9, 2025 — Teleflex secured a major contract with Vizient for its Arrow™ central venous cathetersand arterial catheter sets. This deal strengthens its U.S. hospital penetration.
-
December 10, 2024 — Teleflex expanded its presence in Europe, Middle East, and Africa with the launch of a new Pressure-Injectable Arrowg+ard Blue Plus MSB Procedure Kit, designed to improve catheter safety and placement accuracy.
-
July 31, 2024 — Teleflex received FDA 510(k) clearance for the Ringer™ Perfusion Balloon Catheter, which allows blood flow during long balloon inflation procedures, creating safer cardiovascular treatments.
-
October 23, 2024 — The company introduced two new devices in Canada:
-
Arrow™ VPS Rhythm DLX Device, capable of real-time catheter tip tracking
-
NaviCurve™ Stylet, improving precision in PICC line placements
-
-
2024 — Teleflex also rolled out the Arrow® FlexBlock™ Continuous Peripheral Nerve Block Catheter, supporting regional anesthesia and advanced pain management.
Legal & Regulatory Updates
-
October 6, 2025 — Teleflex and QXMédical reached a patent dispute settlement, clearing the way for the U.S. launch of QXMédical’s Boosting Catheter in 2026.
-
June 13, 2024 — The FDA classified a Teleflex intra-aortic balloon catheter recall as “most serious,”highlighting risks associated with catheter twisting issues during inflation.
-
April 1, 2024 — AngioDynamics settled a major patent dispute with Becton Dickinson (BD), resulting in BD licensing several catheter patents and ending a multi-year legal battle.
These updates reflect an industry that continues to evolve through innovation, regulatory oversight, and competitive positioning.
Market Drivers Supporting Future Growth
Several strong market forces are expected to support growth through 2031:
-
Increasing chronic diseases such as kidney failure, prostate enlargement, diabetes, stroke, and cardiovascular disorders
-
Higher demand for minimally invasive surgeries, especially in cardiology and peripheral vascular disease
-
Adoption of advanced coated catheters to reduce infections and improve patient comfort
-
Rapid expansion of hospitals and specialty clinics in emerging markets
-
Aging global population, which is more prone to catheter-related treatments
-
Technological advancements in materials such as silicone, polyurethane, antimicrobial coatings, and soft-touch polymers
Market Segments Overview
The catheter market includes several major product segments such as cardiovascular catheters, neurovascular catheters, urological catheters, intravenous catheters, and specialty catheters. These products are used across hospitals, clinics, and home-care settings through both direct and distribution channels.
Regionally, North America leads the market due to strong hospital infrastructure, while Asia-Pacific is expanding rapidly due to rising healthcare spending and large patient populations.
Conclusion
The global Catheter Market is entering a strong growth phase, supported by rising medical needs, ongoing product innovations, and increased investment in healthcare facilities. With active launches, FDA clearances, and strategic partnerships across 2024–2025, major companies—especially Teleflex, BD, AngioDynamics, Boston Scientific, Medtronic, and B. Braun—are shaping the next generation of catheter technologies. As hospitals adopt faster and safer treatment methods, the industry is well-positioned for substantial expansion through 2031.
